Keywords: Merck & Co, SmartCells, Diabetes mellitus, Insulin

Merck & Co to acquire insulin developer SmartCells in deal that could exceed $500 million

Article | 03 December 2010

Print This

US drug giant Merck & Co (NYSE: MRK) says it has entered into a definitive agreement under which it will ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in